Asparaginase: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Asparaginase. Educational only — not medical advice.
Labeled uses
RYLAZE is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adult and pediatric patients 1 month or older who have developed hypersensitivity to E. coli -derived asparaginase.
Source: FDA labeling via NIH DailyMed (set 857e53aa…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.